evertex fabrinology limited (TPE:1470)

TPE:1470 Revenue

evertex fabrinology limited had revenue of 191.31M TWD in the quarter ending March 31, 2026, a decrease of -10.58%. This brings the company's revenue in the last twelve months to 781.07M, down -3.78% year-over-year. In the year 2025, evertex fabrinology limited had annual revenue of 803.71M with 1.99% growth.

• Revenue (ttm): 781.07M
• Revenue Growth: -3.78%
• P/S Ratio: 2.47
• Revenue / Employee: 2.80M
• Employees: 279
• Market Cap: 1.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	803.71M	15.67M	1.99%
Dec 31, 2024	788.04M	132.82M	20.27%
Dec 31, 2023	655.22M	-189.93M	-22.47%
Dec 31, 2022	845.15M	-49.64M	-5.55%
Dec 31, 2021	894.79M	264.03M	41.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error